Article

Background rates of five thrombosis with thrombocytopenia syndromes of special interest for COVID-19 vaccine safety surveillance: incidence between 2017 and 2019 and patient profiles from 25.4 million people in six European countries

2021-05-13

Abstract excerpt

<h4>Background</h4> Thrombosis with thrombocytopenia syndrome (TTS) has been reported among individuals vaccinated with adenovirus-vectored COVID-19 vaccines. In this study we describe the background incidence of TTS in 6 European countries. <h4>Methods</h4> Electronic medical records from France, Netherlands, Italy, Germany, Spain, and the United Kingdom informed the study. Incidence rates of cerebral venous sinu...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 30561693-5775-5b2f-b97c-28f1dc2b0d1d
DOI: 10.1101/2021.05.12.21257083

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Background rates of five thrombosis with thrombocytopenia syndromes of special interest for COVID-19 vaccine safety surveillance: incidence between 2017 and 2019 and patient profiles from 25.4 million people in six European countriesDOI 10.1101/2021.05.12.21257083Read

Thrombosis and thrombocytopenia after vaccination against and infection with SARS-CoV-2: a population-based cohort analysisSemantic proximity Read

Background Rates of 41 Adverse Events of Special Interest for COVID-19 Vaccines in 10 European Healthcare Databases - an ACCESS Cohort StudySemantic proximity Read

Background Rates of 41 Adverse Events of Special Interest for COVID-19 Vaccines in 10 European Healthcare Databases - An ACCESS Cohort StudySemantic proximity Read

Phenotype Algorithms for the Identification and Characterization of Vaccine-Induced Thrombotic Thrombocytopenia in Real World Data: A Multinational Network Cohort Study.Semantic proximity Read

INCIDENCE OF VENOUS THROMBOTIC EVENTS AND EVENTS OF SPECIAL INTEREST IN A RETROSPECTIVE COHORT OF COMMERCIALLY-INSURED US PATIENTSSemantic proximity Read

Background rates of hospitalizations and emergency department visits for selected thromboembolic and coagulation disorders in Ontario, Canada, 2015 to 2020, to inform COVID-19 vaccine safety surveillanceSemantic proximity Read

Systemic inflammation in COVID-19 patients may induce various types of venous and arterial thrombosis: A systematic review.Semantic proximity Read

Heparin Induced Thrombocytopenia in Patients with COVID-19Semantic proximity Read

COVID-19 vaccine-associated cerebral venous thrombosis in GermanySemantic proximity Read

Cohort monitoring of 29 Adverse Events of Special Interest prior to and after COVID-19 vaccination in four large European electronic healthcare data sourcesSemantic proximity Read

Arterial and Venous Thrombosis in COVID-19 Disease: From Molecular Pathway to Vaccine AdministrationSemantic proximity Read

COVID-19 Vaccines and Thrombosis—Roadblock or Dead-End Street?Semantic proximity Read